L. Todd Edwards

Chief Commercial OfficeratArcutis Biotherapeutics· In proxies 2023–2025

Pay in FY2025+54% from the year before · Arcutis Biotherapeutics stock +108.5% the same year

L. Todd Edwards was paid $3.0M in FY2025 (Dec), up 54%. Arcutis Biotherapeutics stock rose 108.5% that year.

Pay$100 in the stock at the end of FY22 → $196

Pay is from the Summary Compensation Table of each Arcutis Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

ARQT
Arcutis BiotherapeuticsPublic company · 3 yr
- Chief Commercial Officer2023 – Present · 3 yrStock in role +124%

Roles come from the proxy statements of each company.

Activity

Pay
Arcutis Biotherapeutics Division head pay rose 54% to $3.0M. The stock rose 108% in FY2025 (Dec).
DEF 14AApr 21, 2026
Pay
Arcutis Biotherapeutics Division head pay rose 19% to $2.0M. The stock rose 331% in FY2024 (Dec).
DEF 14AApr 29, 2025

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?